Medical management of asymptomatic primary hyperparathyroidism.
Patients with mild asymptomatic primary hyperparathyroidism who do not meet currently accepted guidelines for surgery may be followed medically. General medical management of these individuals should be directed toward maintaining adequate hydration, therapy of hypertension, and avoiding immobilization. Diuretics should be used only with caution. Moderate dietary calcium intake (500-800 mg/day) should be encouraged. Propranolol and cimetidine are not useful in the therapy of primary hyperparathyroidism. Oral phosphate is efficacious in lowering serum and urinary calcium. However, because of concerns related to ectopic calcification, phosphate is usually reserved for those patients who meet surgical guidelines but who are not to undergo surgery. Bisphosphonates, potent inhibitors of osteoclast-mediated bone resorption, have been shown to lower serum and urinary calcium in patients with primary hyperparathyroidism. However, long-term data on their efficacy in this disorder are not yet available. The use of bisphosphonates at the present time is generally restricted to the research setting. More potent bisphosphonates as well as the design of newer agents that interfere with parathyroid hormone secretion may become very useful in future approaches to the medical management of primary hyperparathyroidism.
Shane
E
E
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.
D000284:Administration, Oral; D002118:Calcium / Q000097:blood / Q000652:urine; D002136:Calcium, Dietary / Q000008:administration & dosage; D002927:Cimetidine / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D006973:Hypertension / Q000628:therapy; D010281:Parathyroid Hormone / Q000378:metabolism; D010710:Phosphates / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use
D002136:Calcium, Dietary; D004164:Diphosphonates; D004232:Diuretics; D010281:Parathyroid Hormone; D010710:Phosphates; D002927:Cimetidine; D011433:Propranolol; D002118:Calcium